Extended-release fluvoxamine (Luvox CR).
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D019540:Area Under Curve; D002648:Child; D003692:Delayed-Action Preparations; D017277:Drug Approval; D016666:Fluvoxamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D003692:Delayed-Action Preparations; D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors